Proteostasis and Disease

Proteostasis and Disease
Author: Rosa Barrio
Publisher: Springer Nature
Total Pages: 350
Release: 2020-04-09
Genre: Science
ISBN: 3030382664

This book, written by members of the European network PROTEOSTASIS, provides an up-to-date review of the research regarding protein homeostasis in health and disease. With new discoveries contributing to the increasing complexity of this topic, the book offers a detailed overview of the pathways regulating protein homeostasis, including autophagy and the ubiquitin protein family. Following a basic introduction, it explains how defects in protein homeostasis contribute to numerous pathologies, including cancer, neurodegeneration, inflammation and a number of rare diseases. In addition, it discusses, the role of protein homeostasis in cellular development and physiology. Highlighting the latest research in the field of protein homeostasis and its implications for various clinically relevant diseases, the book appeals to researchers and clinicians, while also offering a reference guide for scholars who are new to the field.

Medicinal Plants

Medicinal Plants
Author: Bassam Hassan
Publisher: BoD – Books on Demand
Total Pages: 194
Release: 2020-03-25
Genre: Medical
ISBN: 1789858879

This book is focused on clarifying the anticancer effects (i.e., apoptotic, antiproliferative, antimetastatic, antiangiogenic) and mechanisms of most of the medicinal plants found in the world against solid and/or hematological cancers.

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy
Author:
Publisher: Academic Press
Total Pages: 310
Release: 2018-03-28
Genre: Medical
ISBN: 0128137541

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy encompasses recently developed molecular targeting agents and approaches that suppress cell survival signaling. Cell survival signaling attenuates the effectiveness of conventional chemotherapy and numerous mechanisms have been described, and continue to be described, which contribute to cell survival in the face of chemotherapy treatment. Key pathways leading to chemoresistance emanate from growth factor receptors, PI3K, STAT3, anti-apoptotic Bcl-2 family members, autophagy, and the DNA damage response pathway. New advances have underscored the potential of targeting each of these cell survival mechanisms to improve responsiveness to chemotherapy. This book reviews these recent advances and provides a foundational background and hints of new opportunities for basic, translational, and clinical investigators focused on improving therapeutic responses to chemotherapy. - Presents cutting-edge agents and approaches with proved success in different model systems that can be translated to a different type of cancer - Brings updated information to be used to propose new clinical trials investigating innovative strategies for improving responses to chemotherapy - Provides mechanistic details to help guide the design of laboratory studies associated with clinical trials

Biotechnology and Production of Anti-Cancer Compounds

Biotechnology and Production of Anti-Cancer Compounds
Author: Sonia Malik
Publisher: Springer
Total Pages: 334
Release: 2017-04-21
Genre: Science
ISBN: 3319538802

This book discusses cancers and the resurgence of public interest in plant-based and herbal drugs. It also describes ways of obtaining anti-cancer drugs from plants and improving their production using biotechnological techniques. It presents methods such as cell culture, shoot and root culture, hairy root culture, purification of plant raw materials, genetic engineering, optimization of culture conditions as well as metabolic engineering with examples of successes like taxol, shikonin, ingenol mebutate and podophylotoxin. In addition, it describes the applications and limitations of large-scale production of anti-cancer compounds using biotechnological means. Lastly, it discusses future economical and eco-friendly strategies for obtaining anti-cancer compounds using biotechnology.

HER2-Positive Breast Cancer

HER2-Positive Breast Cancer
Author: Sara Hurvitz
Publisher: Elsevier Health Sciences
Total Pages: 265
Release: 2018-07-26
Genre: Medical
ISBN: 0323581234

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists. - Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive. - Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations. - Includes a timely section on innovative future therapies.

Cyclin Dependent Kinase 5 (Cdk5)

Cyclin Dependent Kinase 5 (Cdk5)
Author: Nancy Y. Ip
Publisher: Springer Science & Business Media
Total Pages: 326
Release: 2009-02-28
Genre: Medical
ISBN: 0387788875

Cyclin Dependent Kinase 5 provides a comprehensive and up-to-date collection of reviews on the discovery, signaling mechanisms and functions of Cdk5, as well as the potential implication of Cdk5 in the treatment of neurodegenerative diseases. Since the identification of this unique member of the Cdk family, Cdk5 has emerged as one of the most important signal transduction mediators in the development, maintenance and fine-tuning of neuronal functions and networking. Further studies have revealed that Cdk5 is also associated with the regulation of neuronal survival during both developmental stages and in neurodegenerative diseases. These observations indicate that precise control of Cdk5 is essential for the regulation of neuronal survival. The pivotal role Cdk5 appears to play in both the regulation of neuronal survival and synaptic functions thus raises the interesting possibility that Cdk5 inhibitors may serve as therapeutic treatment for a number of neurodegenerative diseases.

Conservation and Utilization of Threatened Medicinal Plants

Conservation and Utilization of Threatened Medicinal Plants
Author: P.E. Rajasekharan
Publisher: Springer
Total Pages: 565
Release: 2021-07-22
Genre: Science
ISBN: 9783030397951

Medicinal plants are globally valuable sources of herbal products. Plant-based remedies have been used for centuries and have had no alternative in the western medicine repertoire, while others and their bioactive derivatives are in high demand and have been the central focus of biomedical research. As Medicinal plants move from fringe to mainstream with a greater number of individuals seeking treatments free of side effects, considerable attention has been paid to utilize plant-based products for the prevention and cure of human diseases. An unintended consequence of this increased demand, however, is that the existence of many medicinal plants is now threatened, due to their small population size, narrow distribution area, habitat specificity, and destructive mode of harvesting. In addition, climate change, habitat loss and genetic drift have further endangered these unique species. Although extensive research has been carried out on medicinal and aromatic plants, there is relatively little information available on their global distribution patterns, conservation and the associated laws prevailing. This book reviews the current status of threatened medicinal plants in light of increased surge in the demand for herbal medicine. It brings together chapters on both wild (non-cultivated) and domestic (cultivated) species having therapeutic values. Thematically, conventional and contemporary approaches to conservation of such threatened medicinal plants with commercial feasibility are presented. The topics of interest include, but not limited to, biotechnology, sustainable development, in situ and ex situ conservation, and even the relevance of IPR on threatened medicinal plants. We believe this book is useful to horticulturists, botanists, policy makers, conservationists, NGOs and researchers in the academia and the industry sectors.